Manufacturing & Packaging

Financial commitment expected to benefit capabilities of single-use assemblies

Law firm to feature life sciences practice in New Jersey and Philadelphia

Among goals, product aims to mitigate supply chain risk for pharma and biotech industries

Allows CDMO to enhance its therapeutic and vaccine offerings

Will feature additional cell and gene therapy capacity

Collaboration expected to accelerate the bionnovative drug R&D process

Massachusetts facility will support biologics developers in the New England area

Massachusetts facility will be dedicated to offering viral vector production services

Company’s Conroe location will serve as HQ

CDMO’s 76,000 square-foot manufacturing center will be commercial ready

Track-and-trace provider will be incorporating fingerprinting tech into its line

CDMO filling capacity now exceeds 50 million units yearly

Ultra low-temperature freezers continue to change the game in cold chain

Site expected to boost the CDMO’s global drug production capabilities

Growth of CDMO's Pennsylvania facility will feature increase in cold chain storage capacity

Acquisition expands high-potent capabilities, along with oral development and manufacturing capacity

Division will operate under SCHOTT Pharma AG & Co. KGaA

CDMO’s new project focuses on addressing needs in oncology sector

New property is valued at $323 million

Center will feature a $1.4 billion investment plan

Production capacity for the contract manufacturer is expected to more than triple

Will benefit CDMO’s Denmark and Texas locations

With a cost of approximately $514 million, expected completion is 2026

Cheshire facility will offer plasmid DNA production, CGT development

Marks the CDMO’s second plant in the country